Title for MeetingAbstracts
Alphabetical listing of titles
HLA-B, HLA-DRB1, TNF-alpha and ccr5 delta 32 allele and haplotype frequencies and susceptibility to HIV infection in Mexicans.
HLA-B15 subtypes associated with slow HIV disease progression share promiscuously binding, HLA-B27 or HLA-B57 restricted HIV CTL epitopes.
HLA-B35 and progression to AIDS in haemophiliac patients.
HLA-B35 Restricted CD8+ T-cell Responses May Influence Rates of HIV Disease Progression.
HLA-B57 and TNF-alpha Variants Associated with Hypersensitivity Reactions to Abacavir among HIV-1-Positive Subjects.
HLA-Bw4 homozygosity is associated with profound suppression of HIV-1 viremia and long-term non-progression to AIDS.
HLA-DR antigen in neuroendothelium is detected during SIVSM encephalitis.
HLA-DR on T cells enhances HIV-1 expression.
HLA-DR/CD3+cells in HIV-seropositive children at several stages of disease evolution.
HLA-DRB1, -DQB1, and HLA-B Associations with Early HIV-1 Viral Load in Seroconverters from the Multicenter AIDS Cohort Study.
HLA-g is expressed in PBMC from HIV-1+ individuals.
hLF(1-11) Peptide and Fluconazole Act Synergistically against Systemic Infections with Fluconazole-Resistant Candida albicans.
Hm-pao spect and gd-dtpa enhanced mr imaging in cns-manifestations of AIDS.
HMA and phylogenetic analysis for genotyping HIV-1 isolates from cameroon.
HMG-CoA Reductase: a Novel Target for Antimicrobial Chemotherapy.
HMO Clinical Performance: Which Plans Are Improving?
HMO Cost, Quality and Profitability: Evidence on the Trade-Offs.
HMO data systems in population studies of access to care.
HMO enrollment: women's access to care and satisfaction.
HMO Market Penetration and the Adoption of Managed Care Practices in the Medicare Fee-for-Service Sector.
HMO penetration and outcome of hospital services in treating acute myocardial infarction.
HMO Penetration and Outcomes in a Nascent Price-competitive Market.
HMO penetration and the geographical redistribution of generalist and specialist physicians.
HMO replication of social/HMO population-based screening for frail elderly.
HMO survival from 1981 to 1993.
HMOs and hospital risk adjusted mortality rates.
HMOs and medical care technology: global responsibility for assuring cost-effectiveness and local coverage decisions.
HMOs and risk selection.
HMPAO-SPECT in early stages of HIV infection.
HMR 1043: a New Lipopeptide Antibacterials: In Vitro Properties.